MODERNA, INC. |
Market Closed -
Other stock markets
|
After market 04:45:35 pm | |||
| 125.7 USD | +7.13% |
|
126.3 | +0.52% |
| 09:45am | Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing | MT |
| May. 10 | Equities Mostly Rise as Traders Parse Fed Officials' Comments, Consumer Sentiment Survey | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 6,518 | 41,340 | 102,976 | 69,006 | 37,919 | 44,958 | - | - |
| Enterprise Value (EV) 1 | 5,548 | 36,842 | 92,848 | 59,104 | 29,315 | 38,708 | 41,018 | 41,959 |
| P/E ratio | -12.6 x | -53.3 x | 8.98 x | 8.93 x | -8.07 x | -16.6 x | -22.8 x | -78.1 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 108 x | 51.5 x | 5.58 x | 3.58 x | 5.54 x | 10.8 x | 9.3 x | 6.82 x |
| EV / Revenue | 92.1 x | 45.9 x | 5.03 x | 3.07 x | 4.28 x | 9.31 x | 8.48 x | 6.36 x |
| EV / EBITDA | -10.8 x | -50.3 x | 6.86 x | 6.05 x | -8.1 x | -14 x | -19.7 x | -57.6 x |
| EV / FCF | -11.3 x | 18.8 x | 6.96 x | 12.9 x | -7.66 x | -14.3 x | -21.1 x | -64.4 x |
| FCF Yield | -8.84% | 5.32% | 14.4% | 7.75% | -13% | -7.01% | -4.73% | -1.55% |
| Price to Book | 6.14 x | 16.3 x | 7.24 x | 3.7 x | 2.74 x | 3.79 x | 5 x | 6 x |
| Nbr of stocks (in thousands) | 333,250 | 395,710 | 405,450 | 384,180 | 381,284 | 383,240 | - | - |
| Reference price 2 | 19.56 | 104.5 | 254.0 | 179.6 | 99.45 | 117.3 | 117.3 | 117.3 |
| Announcement Date | 2/26/20 | 2/25/21 | 2/24/22 | 2/23/23 | 2/22/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 60.21 | 803.4 | 18,471 | 19,263 | 6,848 | 4,157 | 4,834 | 6,594 |
| EBITDA 1 | -514.7 | -731.9 | 13,528 | 9,768 | -3,618 | -2,773 | -2,077 | -728.9 |
| EBIT 1 | -545.7 | -763.1 | 13,296 | 9,420 | -4,239 | -3,048 | -2,256 | -746.2 |
| Operating Margin | -906.38% | -94.99% | 71.98% | 48.9% | -61.9% | -73.31% | -46.67% | -11.32% |
| Earnings before Tax (EBT) 1 | -514.7 | -744.5 | 13,285 | 9,575 | -3,942 | -2,636 | -1,843 | 141 |
| Net income 1 | -514 | -747.1 | 12,202 | 8,362 | -4,714 | -2,701 | -1,969 | -363.1 |
| Net margin | -853.73% | -92.99% | 66.06% | 43.41% | -68.84% | -64.97% | -40.72% | -5.51% |
| EPS 2 | -1.550 | -1.960 | 28.29 | 20.12 | -12.33 | -7.073 | -5.135 | -1.502 |
| Free Cash Flow 1 | -490.5 | 1,960 | 13,336 | 4,581 | -3,825 | -2,714 | -1,939 | -651.2 |
| FCF margin | -814.7% | 243.91% | 72.2% | 23.78% | -55.86% | -65.28% | -40.12% | -9.88% |
| FCF Conversion (EBITDA) | - | - | 98.58% | 46.9% | - | - | - | - |
| FCF Conversion (Net income) | - | - | 109.29% | 54.78% | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 2/26/20 | 2/25/21 | 2/24/22 | 2/23/23 | 2/22/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 7,211 | 6,066 | 4,749 | 3,364 | 5,084 | 1,862 | 344 | 1,831 | 2,811 | 167 | 139.9 | 1,507 | 2,311 | 579.1 | 429.3 |
| EBITDA 1 | 5,488 | - | - | - | - | - | - | - | 208 | - | -1,351 | -493.4 | - | - | - |
| EBIT 1 | 5,410 | 4,227 | 2,447 | 1,166 | 1,580 | -366 | -1,867 | -2,012 | 6 | -1,266 | -1,331 | -519 | 85.63 | -967.4 | -1,080 |
| Operating Margin | 75.02% | 69.68% | 51.53% | 34.66% | 31.08% | -19.66% | -542.73% | -109.89% | 0.21% | -758.08% | -951.49% | -34.44% | 3.71% | -167.04% | -251.66% |
| Earnings before Tax (EBT) 1 | 5,410 | 4,229 | 2,474 | 1,217 | 1,655 | -305 | -1,749 | -1,958 | 70 | -1,165 | -1,267 | -445.6 | 197.5 | -912.5 | -989.2 |
| Net income 1 | 4,868 | 3,657 | 2,197 | 1,043 | 1,465 | 79 | -1,380 | -3,630 | 217 | -1,175 | -1,285 | -463.4 | 229.5 | -912.5 | -989.2 |
| Net margin | 67.51% | 60.29% | 46.26% | 31% | 28.82% | 4.24% | -401.16% | -198.25% | 7.72% | -703.59% | -917.95% | -30.75% | 9.93% | -157.57% | -230.42% |
| EPS 2 | 11.29 | 8.580 | 5.240 | 2.530 | 3.610 | 0.1900 | -3.620 | -9.530 | 0.5500 | -3.070 | -3.329 | -1.175 | 0.4745 | -2.721 | -2.800 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/24/22 | 5/4/22 | 8/3/22 | 11/3/22 | 2/23/23 | 5/4/23 | 8/3/23 | 11/2/23 | 2/22/24 | 5/2/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 971 | 4,498 | 10,128 | 9,902 | 8,604 | 6,250 | 3,940 | 2,999 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -491 | 1,960 | 13,336 | 4,581 | -3,825 | -2,714 | -1,939 | -651 |
| ROE (net income / shareholders' equity) | -38% | -40% | 146% | 50.3% | -28.6% | -22.1% | -19.1% | -11.3% |
| ROA (Net income/ Total Assets) | -28.9% | -16.7% | 76.2% | 33.1% | -21.3% | -14.7% | -14.4% | -8.37% |
| Assets 1 | 1,776 | 4,463 | 16,003 | 25,264 | 22,142 | 18,347 | 13,717 | 4,339 |
| Book Value Per Share 2 | 3.190 | 6.420 | 35.10 | 48.50 | 36.30 | 30.90 | 23.50 | 19.50 |
| Cash Flow per Share 2 | - | 5.320 | 31.60 | 12.00 | -8.160 | -6.940 | -4.110 | 1.770 |
| Capex 1 | 31.6 | 67.4 | 284 | 400 | 707 | 891 | 507 | 534 |
| Capex / Sales | 52.41% | 8.4% | 1.54% | 2.08% | 10.32% | 21.44% | 10.48% | 8.1% |
| Announcement Date | 2/26/20 | 2/25/21 | 2/24/22 | 2/23/23 | 2/22/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
117.3
USD
Average target price
139.4
USD
Spread / Average Target
+18.79%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +26.51% | 44.96B | |
| -0.72% | 42.65B | |
| +46.00% | 41.85B | |
| -5.31% | 29.04B | |
| +9.35% | 26.08B | |
| -21.66% | 19.03B | |
| +6.29% | 12.75B | |
| +27.64% | 12.06B | |
| -3.51% | 11.75B | |
| +20.16% | 11.72B |
- Stock Market
- Equities
- MRNA Stock
- Financials Moderna, Inc.
